CAS 292141-31-2

Luteinizing Hormone-Releasing Hormone Antagonist trifluoroacetate salt

CAS: 292141-31-2

Luteinizing Hormone-Releasing Hormone Antagonist trifluoroacetate salt is a potent antagonist of the luteinizing hormone-releasing hormone (LHRH) receptor. It is used specifically to treat platinum-resistant ovarian cancer, where it has been shown to be effective in reducing tumor size and volume. This drug has minimal toxicity and can be administered by injection or as a microcapsule. LHRH Antagonist trifluoroacetate salt is an analog of LHRH that has been modified so that it cannot cross the blood-brain barrier. It also binds to epidermal growth factor receptors, which are involved in cell proliferation, differentiation, and survival. Symptoms of overdose may include nausea, vomiting, headache, dizziness, seizures, and coma.

Formel: C₄₈H₅₉ClN₁₂O₈

Reinheit: Min. 95%

Molekulargewicht: 967.51 g/mol

Ref: 3D-FL109452